Thus, the new product causes a shift in the existing product–market structure of an industry. This paper reports on the findings of the analysis of 51 large pharmaceutical firms and their market-creating activities. The study suggests that market-creating firms have capabilities in both R&D and...
The final entry on our list of the top pharmaceutical consulting firms is the self-proclaimed 'world's largest research consulting organization (RCO)', ProPharma. The company ranked in the Inc. 5000 list of the fastest-growing American companies last year, and has plenty of momentum in 2024....
Researchmoz, one of the world’s prominent market research firms has announced a novel report on Global Pharmaceutical Gelatin Market. A new business intelligence report released by Advance Market Analytics with title Pharmaceutical Gelatin Market Insights, Forecast to 2025" has abilities to raise as ...
What sets MarketSense apart from other consulting firms is our focus on personalized attention and external data validation. We work closely with clients and utilize our impressive network of contacts in business development and licensing, medical thought leaders, patient advocacy groups and other expert...
BEIJING, May 10 (Xinhua) -- China's pharmaceutical firms saw their combined business revenue climb 18.7 percent year on year in 2021, the highest growth rate in five years, official data showed Tuesday. Companies in this sector together raked in 3.37 trillion yuan (about 502 billion U.S. ...
At a value of around $137 billion at the end of 2018, the Chinese pharmaceutical market has surpassed Japan to become the world's second-largest by sales after the United States, the report said, citing data from market research firm IQVIA. ...
Signs of a reopening of the IPO market also bode well for the subsector as the continued funding of R&D activities is critical to getting their products to market. We expect areas such as radiopharmaceuticals and immunology to see healthy activity and expect that the nascent trend of China-to...
Korean pharmaceutical firms aim to list subsidiaries on stock market for more R&D Affiliates or subsidiaries of Korean pharmaceutical companies have been announcing their plans to conduct an initial public offering (IPO) to secure funds for clinical research and develop new drugs....
However, small firms with a history ofpartneringto get drugs out of the lab and into the world are worth considering. When it comes to acquisitions, large companies typically look for smaller firms valued at $1 billion to $6 billion, with drug candidates in late-stage clinical trials or com...
Highlighting this trend, the Biden administration secured USD 7.5 billion in savings through a pact with pharmaceutical firms, capping prices on the ten priciest medications. This agreement, projected to slash net Medicare expenses by 22% (equating to USD 6 billion), underscores the government's pi...